deflazacort 6 MG Oral Tablet [Kymbee]
- RxCUI
- 2725491
- RxNorm name
- deflazacort 6 MG Oral Tablet [Kymbee]
- Display name
- deflazacort 6 MG Oral Tablet [Kymbee]
- Full name
- deflazacort 6 MG Oral Tablet [Kymbee]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:07
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| KYMBEE | DEFLAZACORT | Upsher-Smith Laboratories, LLC | 89365f9f-a7ae-40d3-aecc-e4add75d21c2 | 2025-07-17 | Warnings, Adverse reactions | 2725491 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 89365f9f-a7ae-40d3-aecc-e4add75d21c2 | KYMBEE 6 MG Oral Tablet [PSN] · deflazacort 6 MG Oral Tablet [Kymbee] [SBD] · Kymbee 6 MG Oral Tablet [SY] | 3 | 1 | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KYMBEE safely and effectively. See full prescribing information for KYMBEE. KYMBEE TM (deflazacort) tablets, for oral use Initial U.S. Approval: 2017 | 20250717 |